KURA · CIK 0001422143 · operating
Kura Oncology, Inc. (KURA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $755 million, Kura Oncology, Inc. is a small-cap company. The stock currently trades at $8.68, down 0.57% today, with a 52-week range of $5.41–$12.49.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-2.02 | $-2.02 | +2.9% | |
| 2023 | $-2.08 | $-2.08 | -2.5% | |
| 2022 | $-2.03 | $-2.03 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-02-28 | 0000950170-25-029975 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0000950170-24-021094 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0000950170-23-004107 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0000950170-22-001967 | SEC ↗ |
| 2020-12-31 | 2021-02-24 | 0001564590-21-007822 | SEC ↗ |
| 2019-12-31 | 2020-02-25 | 0001564590-20-006391 | SEC ↗ |
| 2018-12-31 | 2019-03-05 | 0001564590-19-006263 | SEC ↗ |
| 2017-12-31 | 2018-03-12 | 0001564590-18-005293 | SEC ↗ |
| 2016-12-31 | 2017-03-14 | 0001564590-17-004291 | SEC ↗ |
| 2015-12-31 | 2016-03-17 | 0001564590-16-014998 | SEC ↗ |
| 2014-12-31 | 2015-02-27 | 0001213900-15-001429 | SEC ↗ |
| 2013-12-31 | 2014-03-31 | 0001213900-14-001896 | SEC ↗ |
| 2012-12-31 | 2013-03-28 | 0001144204-13-018035 | SEC ↗ |
| 2011-12-31 | 2012-03-30 | 0001144204-12-018805 | SEC ↗ |
| 2010-12-31 | 2011-03-31 | 0001144204-11-019036 | SEC ↗ |
| 2009-12-31 | 2010-03-31 | 0001144204-10-017289 | SEC ↗ |
| 2008-12-31 | 2009-03-31 | 0001144204-09-017640 | SEC ↗ |